Advertisement
Screener

Gartner, Inc. (IT) Other Cost of Operating Revenue

3.2 / 5 stars · 76/120 Roast Me

Gartner, Inc. Other Cost of Operating Revenue

Gartner, Inc. (IT) reported Other Cost of Operating Revenue of $9.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OtherCostOfOperatingRevenue · last filed 2026-08-04

  • Gartner, Inc. other cost of operating revenue for the quarter ending 2026-06-30 was $9.33M, a 222.28% increase year-over-year.
  • Gartner, Inc. other cost of operating revenue for the quarter ending 2026-03-31 was $4.57M, a 26.21% decline year-over-year.
  • Gartner, Inc. other cost of operating revenue for the quarter ending 2025-12-31 was $8.40M, a 73.04% increase year-over-year.
  • Gartner, Inc. other cost of operating revenue for the quarter ending 2025-09-30 was $7.07M, a 9.34% increase year-over-year.
  • Gartner, Inc. other cost of operating revenue for fiscal 2025 was $24.57M, a 25.91% decline from fiscal 2024.
  • Gartner, Inc. other cost of operating revenue for fiscal 2024 was $33.16M, a 4.70% increase from fiscal 2023.
  • Gartner, Inc. other cost of operating revenue for fiscal 2023 was $31.67M, a 4.21% decline from fiscal 2022.
  • Gartner, Inc. other cost of operating revenue for fiscal 2022 was $33.06M.
Period endOther Cost of Operating Revenue 3 monthOther Cost of Operating Revenue 6 monthOther Cost of Operating Revenue 9 monthOther Cost of Operating Revenue 12 month
2026-06-30$9.33M
10-Q · filed 2026-08-04
$13.90M
10-Q · filed 2026-08-04
$22.30M
derived: sum of 3 quarters · filed 2026-08-04
$29.38M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$4.57M
10-Q · filed 2026-05-05
$12.97M
derived: sum of 2 quarters · filed 2026-05-05
$20.05M
derived: sum of 3 quarters · filed 2026-05-05
$22.94M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$8.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$15.47M
derived: sum of 2 quarters · filed 2026-02-12
$18.37M
derived: sum of 3 quarters · filed 2026-08-04
$24.57M
10-K · filed 2026-02-12
2025-09-30$7.07M
10-Q · filed 2025-11-04
$9.97M
derived: sum of 2 quarters · filed 2026-08-04
$16.16M
10-Q · filed 2025-11-04
$21.02M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$2.90M
10-Q · filed 2026-08-04
$9.09M
10-Q · filed 2026-08-04
$13.95M
derived: sum of 3 quarters · filed 2026-08-04
$20.41M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$6.20M
10-Q · filed 2026-05-05
$11.05M
derived: sum of 2 quarters · filed 2026-05-05
$17.52M
derived: sum of 3 quarters · filed 2026-05-05
$30.73M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$11.32M
derived: sum of 2 quarters · filed 2026-02-12
$24.53M
derived: sum of 3 quarters · filed 2026-02-12
$33.16M
10-K · filed 2026-02-12
2024-09-30$6.47M
10-Q · filed 2025-11-04
$19.67M
derived: sum of 2 quarters · filed 2025-11-04
$28.30M
10-Q · filed 2025-11-04
2024-06-30$13.21M
10-Q · filed 2025-08-05
$21.83M
10-Q · filed 2025-08-05
2024-03-31$8.63M
10-Q · filed 2025-05-06
2023-12-31$31.67M
10-K · filed 2026-02-12
2022-12-31$33.06M
10-K · filed 2025-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
FRANKLIN COVEY CO (FC)United States$0.195B123.76